Aberdeen Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-40,812
| Closed | -$4.72M | – | 993 |
|
|
2023
Q3 | $4.72M | Sell |
40,812
-16,941
| -29% | -$1.82M | 0.01% | 564 |
|
|
2023
Q2 | $5.94M | Sell |
57,753
-103,911
| -64% | -$11M | 0.01% | 549 |
|
|
2023
Q1 | $17.6M | Sell |
161,664
-1,684,822
| -91% | -$186M | 0.04% | 369 |
|
|
2022
Q4 | $210M | Sell |
1,846,486
-69,431
| -4% | -$5.77M | 0.57% | 36 |
|
|
2022
Q3 | $119M | Sell |
1,915,917
-183,607
| -9% | -$12.8M | 0.35% | 64 |
|
|
2022
Q2 | $171M | Buy |
2,099,524
+10,798
| +0.5% | +$1.02M | 0.54% | 41 |
|
|
2022
Q1 | $221M | Buy |
2,088,726
+258,346
| +14% | +$25.2M | 0.57% | 40 |
|
|
2021
Q4 | $197M | Sell |
1,830,380
-42,486
| -2% | -$4.63M | 0.43% | 58 |
|
|
2021
Q3 | $205M | Buy |
1,872,866
+56,265
| +3% | +$5.84M | 0.46% | 52 |
|
|
2021
Q2 | $170M | Sell |
1,816,601
-77,600
| -4% | -$7.14M | 0.37% | 67 |
|
|
2021
Q1 | $174M | Buy |
1,894,201
+134,636
| +8% | +$11.4M | 0.4% | 66 |
|
|
2020
Q4 | $129M | Sell |
1,759,565
-284,978
| -14% | -$21.2M | 0.31% | 79 |
|
|
2020
Q3 | $159M | Sell |
2,044,543
-78,734
| -4% | -$5.42M | 0.42% | 64 |
|
|
2020
Q2 | $118M | Sell |
2,123,277
-146,241
| -6% | -$6.26M | 0.32% | 82 |
|
|
2020
Q1 | $67.2M | Buy |
2,269,518
+429,800
| +23% | +$14.5M | 0.21% | 99 |
|
|
2019
Q4 | $66.6M | Buy |
1,839,718
+346,321
| +23% | +$10.6M | 0.16% | 111 |
|
|
2019
Q3 | $40.7M | Buy |
+1,493,397
| New | +$38.6M | 0.1% | 169 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB